21![Hep C Guidelines.qxd[removed]:01 PM Hep C Guidelines.qxd[removed]:01 PM](https://www.pdfsearch.io/img/54fe5b7fa253d34471aea4cc8f3381c7.jpg) | Add to Reading ListSource URL: www.liver.caLanguage: English - Date: 2012-11-22 19:09:03
|
---|
22![Pediatric Postmarket Pharmacovigilance and Drug Utilization Review (PEGASYS/COPEGUS) Pediatric Postmarket Pharmacovigilance and Drug Utilization Review (PEGASYS/COPEGUS)](https://www.pdfsearch.io/img/8314affc086c55f7e95cd42c044a6e45.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
23![These highlights do not include all the information needed to use PegIntron safely and effectively. See full prescribing information for PegIntron. PegIntron (Peginterferon alfa-2b) Injection, Powder for Solution for Su These highlights do not include all the information needed to use PegIntron safely and effectively. See full prescribing information for PegIntron. PegIntron (Peginterferon alfa-2b) Injection, Powder for Solution for Su](https://www.pdfsearch.io/img/dd811f6e5cf7cfbd3888c7f159a15209.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
24![Drugs/Medications Known to Cause Hyperhidrosis Certain prescriptions and non-prescription medications can cause hyperhidrosis (excess perspiration or sweating) as a side effect. A list of potentially sweat-inducing medic Drugs/Medications Known to Cause Hyperhidrosis Certain prescriptions and non-prescription medications can cause hyperhidrosis (excess perspiration or sweating) as a side effect. A list of potentially sweat-inducing medic](https://www.pdfsearch.io/img/c1f56afa74dd06f803f41d405b6a69db.jpg) | Add to Reading ListSource URL: www.sweathelp.orgLanguage: English - Date: 2012-02-27 16:49:27
|
---|
25![HepC_CATIE_LOGO_NoInfo_BI_CMYK HepC_CATIE_LOGO_NoInfo_BI_CMYK](https://www.pdfsearch.io/img/4e00e9eaf1d72c63bc868acc74ae40ee.jpg) | Add to Reading ListSource URL: www.pasan.orgLanguage: English - Date: 2010-02-21 20:22:33
|
---|
26![Microsoft Word - Hepatitis C Treatment Medications & Dosing.doc Microsoft Word - Hepatitis C Treatment Medications & Dosing.doc](https://www.pdfsearch.io/img/b13578b20e4288d441794c5c6a26c197.jpg) | Add to Reading ListSource URL: anthctoday.orgLanguage: English - Date: 2014-07-21 13:19:06
|
---|
27![1625 Massachusetts Avenue NW, Suite 300 Washington, DC[removed]www.graycary,com O[removed]F[removed] 1625 Massachusetts Avenue NW, Suite 300 Washington, DC[removed]www.graycary,com O[removed]F[removed]](https://www.pdfsearch.io/img/dc5c4f6c63bd0d735f339ba62f6ba694.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2003-11-12 17:50:31
|
---|
28![Medications Requiring a Prior Authorization Due to the characteristics of certain medications, it is necessary to have a physician prior authorize them. The list below includes medications that fall into this classificat Medications Requiring a Prior Authorization Due to the characteristics of certain medications, it is necessary to have a physician prior authorize them. The list below includes medications that fall into this classificat](https://www.pdfsearch.io/img/9af2b6573c0e67bf16e649a478d99d04.jpg) | Add to Reading ListSource URL: www.pbmplus.comLanguage: English - Date: 2013-07-11 11:39:32
|
---|
29![HCV Treatment: Interferon and Ribavirin HCV Treatment: Interferon and Ribavirin](https://www.pdfsearch.io/img/ab03b9a337c862907232f4a593b23c43.jpg) | Add to Reading ListSource URL: hcvadvocate.orgLanguage: English - Date: 2014-09-18 02:16:23
|
---|
30![PBTC-039 – Summary for Patients and Families Title: PBTC-039, Phase II study of Peginterferon alfa-2b (PEGIntron) for pediatric patients with unresectable or recurrent craniopharyngioma This is a brief summary of a cli PBTC-039 – Summary for Patients and Families Title: PBTC-039, Phase II study of Peginterferon alfa-2b (PEGIntron) for pediatric patients with unresectable or recurrent craniopharyngioma This is a brief summary of a cli](https://www.pdfsearch.io/img/aa1aed5655313c3acb41ee8d5bebac65.jpg) | Add to Reading ListSource URL: www.pbtc.orgLanguage: English - Date: 2013-12-23 10:31:23
|
---|